Estudo de coorte | Entre pacientes com hepatite B resolvida e doenças autoimunes concomitantes, a exposição a doses de prednisona maiores que 20 mg/dia foi associada com alto risco para reativação do vírus da hepatite B (VHB) ou surto de hepatite.

Average corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection – Annals of Rheumatic Disease (link para o resumo – $ para o texto completo)

Comentário no Twitter

Patients with time-weighted average prednisone dose greater than 20 mg/day would be classified as the high risk for HBV reactivation or hepatitis flare. Prophylactic Anti-HBV therapy may be needed for these high-risk patientshttps://t.co/qLuirdyXDK pic.twitter.com/yDJ4c072qm

— ARD & RMD Open (@ARD_BMJ) December 23, 2021